{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T04:31:12Z","timestamp":1774326672093,"version":"3.50.1"},"reference-count":38,"publisher":"Frontiers Media SA","issue":"5","license":[{"start":{"date-parts":[[2018,1,16]],"date-time":"2018-01-16T00:00:00Z","timestamp":1516060800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2018,1,16]],"date-time":"2018-01-16T00:00:00Z","timestamp":1516060800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transpl Int"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1111\/tri.13085","type":"journal-article","created":{"date-parts":[[2017,10,23]],"date-time":"2017-10-23T06:30:40Z","timestamp":1508740240000},"page":"484-494","source":"Crossref","is-referenced-by-count":28,"title":["Impact of antiviral prophylaxis in adults Epstein-Barr Virus-seronegative kidney recipients on early and late post-transplantation lymphoproliferative disorder onset: a retrospective cohort study"],"prefix":"10.3389","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0618-6187","authenticated-orcid":false,"given":"Simon","family":"Ville","sequence":"first","affiliation":[{"name":"Centre de Recherche en Transplantation et Immunologie UMR 1064; INSERM, Universit\u00e9 de Nantes; Nantes France"},{"name":"Institut de Transplantation Urologie N\u00e9phrologie (ITUN); CHU Nantes; Nantes France"},{"name":"Service de N\u00e9phrologie Immunologie-clinique; CHU Nantes; Nantes France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berthe-Marie","family":"Imbert-Marcille","sequence":"additional","affiliation":[{"name":"Centre de Recherche en Transplantation et Immunologie UMR 1064; INSERM, Universit\u00e9 de Nantes; Nantes France"},{"name":"Institut de Transplantation Urologie N\u00e9phrologie (ITUN); CHU Nantes; Nantes France"},{"name":"Laboratoire de Virologie; CHU Nantes; Nantes France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianne","family":"Coste-Burel","sequence":"additional","affiliation":[{"name":"Laboratoire de Virologie; CHU Nantes; Nantes France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Garandeau","sequence":"additional","affiliation":[{"name":"Centre de Recherche en Transplantation et Immunologie UMR 1064; INSERM, Universit\u00e9 de Nantes; Nantes France"},{"name":"Institut de Transplantation Urologie N\u00e9phrologie (ITUN); CHU Nantes; Nantes France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aur\u00e9lie","family":"Meurette","sequence":"additional","affiliation":[{"name":"Centre de Recherche en Transplantation et Immunologie UMR 1064; INSERM, Universit\u00e9 de Nantes; Nantes France"},{"name":"Institut de Transplantation Urologie N\u00e9phrologie (ITUN); CHU Nantes; Nantes France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Cantarovitch","sequence":"additional","affiliation":[{"name":"Centre de Recherche en Transplantation et Immunologie UMR 1064; INSERM, Universit\u00e9 de Nantes; Nantes France"},{"name":"Institut de Transplantation Urologie N\u00e9phrologie (ITUN); CHU Nantes; Nantes France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magali","family":"Giral","sequence":"additional","affiliation":[{"name":"Centre de Recherche en Transplantation et Immunologie UMR 1064; INSERM, Universit\u00e9 de Nantes; Nantes France"},{"name":"Institut de Transplantation Urologie N\u00e9phrologie (ITUN); CHU Nantes; Nantes France"},{"name":"Service de N\u00e9phrologie Immunologie-clinique; CHU Nantes; Nantes France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryvonne","family":"Hourmant","sequence":"additional","affiliation":[{"name":"Centre de Recherche en Transplantation et Immunologie UMR 1064; INSERM, Universit\u00e9 de Nantes; Nantes France"},{"name":"Institut de Transplantation Urologie N\u00e9phrologie (ITUN); CHU Nantes; Nantes France"},{"name":"Service de N\u00e9phrologie Immunologie-clinique; CHU Nantes; Nantes France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilles","family":"Blancho","sequence":"additional","affiliation":[{"name":"Centre de Recherche en Transplantation et Immunologie UMR 1064; INSERM, Universit\u00e9 de Nantes; Nantes France"},{"name":"Institut de Transplantation Urologie N\u00e9phrologie (ITUN); CHU Nantes; Nantes France"},{"name":"Service de N\u00e9phrologie Immunologie-clinique; CHU Nantes; Nantes France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques","family":"Dantal","sequence":"additional","affiliation":[{"name":"Centre de Recherche en Transplantation et Immunologie UMR 1064; INSERM, Universit\u00e9 de Nantes; Nantes France"},{"name":"Institut de Transplantation Urologie N\u00e9phrologie (ITUN); CHU Nantes; Nantes France"},{"name":"Service de N\u00e9phrologie Immunologie-clinique; CHU Nantes; Nantes France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2018,1,16]]},"reference":[{"key":"10.1111\/tri.13085-BIB0001|tri13085-cit-0001","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1001\/jama.2011.1592","article-title":"Spectrum of cancer risk among US solid organ transplant recipients","volume":"306","author":"Engels","year":"2011","journal-title":"JAMA"},{"key":"10.1111\/tri.13085-BIB0002|tri13085-cit-0002","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1001\/jama.296.23.2823","article-title":"Cancer incidence before and after kidney transplantation","volume":"296","author":"Vajdic","year":"2006","journal-title":"JAMA"},{"key":"10.1111\/tri.13085-BIB0003|tri13085-cit-0003","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/j.1600-6143.2011.03896.x","article-title":"Epidemiology of posttransplant lymphoproliferative disorders in adult kidney and kidney pancreas recipients: report of the French registry and analysis of subgroups of lymphomas: PTLD French Registry","volume":"12","author":"Caillard","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.13085-BIB0004|tri13085-cit-0004","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/ajt.12004","article-title":"Epstein-Barr virus infection and posttransplant lymphoproliferative disorder: EBV and PTLD","volume":"13","author":"Green","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.13085-BIB0005|tri13085-cit-0005","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1097\/TP.0b013e3181b9692d","article-title":"Epidemiology of pretransplant EBV and CMV serostatus in relation to posttransplant non-Hodgkin lymphoma","volume":"88","author":"Opelz","year":"2009","journal-title":"Transplantation"},{"key":"10.1111\/tri.13085-BIB0006|tri13085-cit-0006","doi-asserted-by":"crossref","first-page":"15088","DOI":"10.1038\/nrdp.2015.88","article-title":"Post-transplant lymphoproliferative disorders","volume":"2","author":"Dharnidharka","year":"2016","journal-title":"Nat Rev Dis Primer"},{"key":"10.1111\/tri.13085-BIB0007|tri13085-cit-0007","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1399-0012.1995.tb00297.x","article-title":"Antiviral prophylaxis and the Epstein Barr virus-related post-transplant lymphoproliferative disorder","volume":"9","author":"Davis","year":"1995","journal-title":"Clin Transplant"},{"key":"10.1111\/tri.13085-BIB0008|tri13085-cit-0008","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1097\/00007890-199709270-00010","article-title":"Reduced incidence of Epstein-Barr virus-associated posttransplant lymphoproliferative disorder using preemptive antiviral therapy","volume":"64","author":"Darenkov","year":"1997","journal-title":"Transplantation"},{"key":"10.1111\/tri.13085-BIB0009|tri13085-cit-0009","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1097\/00007890-199812270-00006","article-title":"Prevention and preemptive therapy of posttransplant lymphoproliferative disease in pediatric liver recipients","volume":"66","author":"McDiarmid","year":"1998","journal-title":"Transplantation"},{"key":"10.1111\/tri.13085-BIB0010|tri13085-cit-0010","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S1053-2498(01)00407-7","article-title":"Anti-viral prophylaxis reduces the incidence of lymphoproliferative disease in lung transplant recipients","volume":"21","author":"Malouf","year":"2002","journal-title":"J Heart Lung Transplant"},{"key":"10.1111\/tri.13085-BIB0011|tri13085-cit-0011","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1111\/j.1600-6143.2005.01115.x","article-title":"Ganciclovir and acyclovir reduce the risk of post-transplant lymphoproliferative disorder in renal transplant recipients: anti-virals reduce risk of PTLD","volume":"5","author":"Funch","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.13085-BIB0012|tri13085-cit-0012","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S1470-2045(07)70040-2","article-title":"Effect of cytomegalovirus prophylaxis with immunoglobulin or with antiviral drugs on post-transplant non-Hodgkin lymphoma: a multicentre retrospective analysis","volume":"8","author":"Opelz","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1111\/tri.13085-BIB0013|tri13085-cit-0013","doi-asserted-by":"crossref","first-page":"12140","DOI":"10.1128\/JVI.78.22.12140-12146.2004","article-title":"Expression and localization of the Epstein-Barr virus-encoded protein kinase","volume":"78","author":"Gershburg","year":"2004","journal-title":"J Virol"},{"key":"10.1111\/tri.13085-BIB0014|tri13085-cit-0014","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJM198204153061506","article-title":"Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation","volume":"306","author":"Hanto","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1111\/tri.13085-BIB0015|tri13085-cit-0015","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/jmv.21334","article-title":"Cellular normalization of viral DNA loads on whole blood improves the clinical management of cytomegalovirus or Epstein Barr virus infections in the setting of pre-emptive therapy","volume":"81","author":"Bressollette-Bodin","year":"2009","journal-title":"J Med Virol"},{"key":"10.1111\/tri.13085-BIB0016|tri13085-cit-0016","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/cid\/cis823","article-title":"Epidemiology and morbidity of Epstein-Barr virus infection in pediatric renal transplant recipients: a multicenter, prospective study","volume":"56","author":"Hocker","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1111\/tri.13085-BIB0017|tri13085-cit-0017","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/tid.12533","article-title":"Primary Epstein-Barr virus infection, seroconversion, and post-transplant lymphoproliferative disorder in seronegative renal allograft recipients: a prospective cohort study","volume":"18","author":"Hosseini-Moghaddam","year":"2016","journal-title":"Transpl Infect Dis"},{"key":"10.1111\/tri.13085-BIB0018|tri13085-cit-0018","first-page":"378","article-title":"Human B-cell lymphoma in severe combined immunodeficient mice after active infection with Epstein-Barr virus","volume":"112","author":"Boyle","year":"1992","journal-title":"Surgery"},{"key":"10.1111\/tri.13085-BIB0019|tri13085-cit-0019","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1034\/j.1399-3062.2001.003002097.x","article-title":"The role of antiviral and immunoglobulin therapy in the prevention of Epstein-Barr virus infection and post-transplant lymphoproliferative disease following solid organ transplantation","volume":"3","author":"Green","year":"2001","journal-title":"Transpl Infect Dis"},{"key":"10.1111\/tri.13085-BIB0020|tri13085-cit-0020","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/j.1432-2277.2012.01485.x","article-title":"(Val-)Ganciclovir prophylaxis reduces Epstein-Barr virus primary infection in pediatric renal transplantation: (Val-)Ganciclovir reduces EBV primary infection","volume":"25","author":"H\u00f6cker","year":"2012","journal-title":"Transpl Int"},{"key":"10.1111\/tri.13085-BIB0021|tri13085-cit-0021","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1111\/j.1600-6143.2011.03478.x","article-title":"Monitoring infection with Epstein-Barr virus among seromismatch adult renal transplant recipients: preventing PTLD in EBV mismatch transplants","volume":"11","author":"Martin","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.13085-BIB0022|tri13085-cit-0022","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/ajt.14020","article-title":"The role of antiviral prophylaxis for the prevention of Epstein-Barr virus-associated posttransplant lymphoproliferative disease in solid organ transplant recipients: a systematic review","volume":"17","author":"AlDabbagh","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.13085-BIB0023|tri13085-cit-0023","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.transproceed.2010.02.042","article-title":"Risk factors for posttransplant lymphoproliferative disorder in pediatric liver transplant recipients with cytomegalovirus antigenemia","volume":"42","author":"Kim","year":"2010","journal-title":"Transplant Proc"},{"key":"10.1111\/tri.13085-BIB0024|tri13085-cit-0024","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/00007890-200208150-00013","article-title":"Response of elevated Epstein-Barr virus DNA levels to therapeutic changes in pediatric liver transplant patients: 56-month follow up and outcome","volume":"74","author":"Holmes","year":"2002","journal-title":"Transplantation"},{"key":"10.1111\/tri.13085-BIB0025|tri13085-cit-0025","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1097\/00007890-199904150-00023","article-title":"Prospective longitudinal analysis of quantitative Epstein-Barr virus polymerase chain reaction in pediatric liver transplant recipients","volume":"67","author":"Kogan","year":"1999","journal-title":"Transplantation"},{"key":"10.1111\/tri.13085-BIB0026|tri13085-cit-0026","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1016\/j.transproceed.2009.07.059","article-title":"The role of valacyclovir on Epstein-Barr virus viral loads in pediatric liver transplantation patients","volume":"41","author":"Oz\u00e7ay","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1111\/tri.13085-BIB0027|tri13085-cit-0027","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.TP.0000128611.71038.0C","article-title":"Epstein-Barr virus primary mismatching and HLA matching: key risk factors for post lung transplant lymphoproliferative disease","volume":"78","author":"Wong","year":"2004","journal-title":"Transplantation"},{"key":"10.1111\/tri.13085-BIB0028|tri13085-cit-0028","first-page":"1161","article-title":"Incidence and outcome of primary Epstein-Barr virus infection and lymphoproliferative disease in pediatric heart transplant recipients","volume":"17","author":"Zangwill","year":"1998","journal-title":"J Heart Lung Transplant"},{"key":"10.1111\/tri.13085-BIB0029|tri13085-cit-0029","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/j.1600-6143.2011.03893.x","article-title":"Associations between EBV serostatus and organ transplant type in PTLD risk: an analysis of the SRTR National Registry Data in the United States","volume":"12","author":"Dharnidharka","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.13085-BIB0030|tri13085-cit-0030","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1056\/NEJMra032015","article-title":"Persistence of the Epstein-Barr virus and the origins of associated lymphomas","volume":"350","author":"Thorley-Lawson","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1111\/tri.13085-BIB0031|tri13085-cit-0031","doi-asserted-by":"crossref","first-page":"13993","DOI":"10.1128\/JVI.79.22.13993-14003.2005","article-title":"Epstein-Barr virus lytic infection contributes to lymphoproliferative disease in a SCID mouse model","volume":"79","author":"Hong","year":"2005","journal-title":"J Virol"},{"key":"10.1111\/tri.13085-BIB0032|tri13085-cit-0032","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1128\/JVI.01512-10","article-title":"A new model of Epstein-Barr virus infection reveals an important role for early lytic viral protein expression in the development of lymphomas","volume":"85","author":"Ma","year":"2011","journal-title":"J Virol"},{"key":"10.1111\/tri.13085-BIB0033|tri13085-cit-0033","doi-asserted-by":"crossref","first-page":"e01574","DOI":"10.1128\/mBio.01574-15","article-title":"Knockout of Epstein-Barr virus BPLF1 retards B-cell transformation and lymphoma formation in humanized mice","volume":"6","author":"Whitehurst","year":"2015","journal-title":"MBio"},{"key":"10.1111\/tri.13085-BIB0034|tri13085-cit-0034","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1038\/modpathol.2014.68","article-title":"In vivo intratumoral Epstein-Barr virus replication is associated with XBP1 activation and early-onset post-transplant lymphoproliferative disorders with prognostic implications","volume":"27","author":"Gonzalez-Farre","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1111\/tri.13085-BIB0035|tri13085-cit-0035","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1093\/clinids\/20.5.1346","article-title":"Pretransplantation assessment of the risk of lymphoproliferative disorder","volume":"20","author":"Walker","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1111\/tri.13085-BIB0036|tri13085-cit-0036","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1086\/514142","article-title":"Posttransplant lymphoproliferative disease in primary Epstein-Barr virus infection after liver transplantation: the role of cytomegalovirus disease","volume":"176","author":"Ma\u00f1ez","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1111\/tri.13085-BIB0037|tri13085-cit-0037","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/0895-4356(95)00510-2","article-title":"Importance of events per independent variable in proportional hazards analysis I. Background, goals, and general strategy","volume":"48","author":"Concato","year":"1995","journal-title":"J Clin Epidemiol"},{"key":"10.1111\/tri.13085-BIB0038|tri13085-cit-0038","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/aje\/kwk052","article-title":"Relaxing the rule of ten events per variable in logistic and Cox regression","volume":"165","author":"Vittinghoff","year":"2007","journal-title":"Am J Epidemiol"}],"container-title":["Transplant International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Ftri.13085","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/tri.13085\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T17:12:15Z","timestamp":1750957935000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/tri.13085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,16]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"URL":"https:\/\/doi.org\/10.1111\/tri.13085","archive":["Portico"],"relation":{},"ISSN":["0934-0874"],"issn-type":[{"value":"0934-0874","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1,16]]}}}